Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,678.00    20.00 (1.21%)
Bid:
1,676.00
Ask:
1,680.00
Spread: 4.00 (0.239%)
Market Cap: £494.20m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Director/PDMR Shareholding

29 Nov 2013 15:02

RNS Number : 3343U
Avon Rubber PLC
29 November 2013
 



29 November 2013

 

Avon Rubber p.l.c. ("the Company")

Directors' and PDMRs' Interest in Shares

As disclosed in the 2013 annual report, awards representing 100% of the maximum possible award under the Avon Rubber p.l.c. Performance Share Plan 2010, were granted to Executive Directors, persons discharging managerial responsibilities ('PDMRs') and other employees (together 'Participants') on 1 December 2010 ('the 2010 Awards'). The Awards were made subject to a performance condition based on the Company's Total Shareholder Return ('TSR') relative to the TSR of a comparator group, to be measured over a 3 year performance period which commenced on 1 October 2010 and ended on 30 September 2013. The Company's TSR performance by reference to the comparator group was measured over the 5 days following the announcement of the Company's annual results for the year ended 30 September 2013. The Remuneration Committee confirmed on 28 November 2013 that the Awards vested in full.

The Company has received valid notices from the Participants in respect of the 2010 Awards. As a result, UK Participants have, pursuant to the terms of the relevant joint ownership awards, sold their vested interests over all jointly owned shares in the market and exercised their nil cost options to acquire whole shares in the Company (all tax and National Insurance liabilities associated with the vesting of the 2010 Awards have been met out of the sale proceeds due to the UK Participants). US Participants have acquired whole shares pursuant to their 2010 Awards and sold a number of shares to meet tax and social security liabilities. A number of sales of the whole shares by Participants and their connected persons were also carried out for personal reasons.

Following these transactions, in accordance with the shareholding guidelines referred to in the annual report, both the Executive Directors have a retained shareholding equivalent to at least one and a half times base salary.

The table below sets out the total number of shares over which the 2010 Awards were made to the Executive Directors and PDMRs, total disposals, the net increase in the shares owned by the relevant individuals and their total shareholdings following these transactions (details in respect of connected persons are set out in the notes):

Total Award*

Whole shares acquired under nil cost option or conditional award

Whole shares disposed**

Net increase in shareholding

Total shareholding***

Executive Directors

Peter Slabbert

123,424

46,531

31,265

15,266

202,427

Andrew Lewis

68,067

25,662

5,311

20,351

120,892

PDMRs

Miles Ingrey-Counter

30,725

11,583

6,000

5,583

40,040

Paul McDonald

29,149

10,989

10,989

nil

38,874

John Kime (US)

42,163

42,163

26,983

15,180

15,180

*Each executive held an interest in the number of shares shown in the above table which was sold, on 29 November, following the vesting of the 2010 Awards. The proceeds due to the executives on sale of the jointly owned shares were determined by the 2010 Joint Ownership Agreements as £3.52 per share.

** Some of the whole shares disposed were sold from pre-existing holdings by spouses and, in the case of Peter Slabbert, his son. Specifically, Desiree Slabbert sold 3,800 shares, Simon Slabbert sold 4,200 shares, Karen Lewis sold 4,200 shares and Emma Ingrey-Counter sold 4,200 shares.

**\* This excludes interests held under unvested joint ownership awards. The total shareholding number includes shares held by connected persons. In respect of Peter Slabbert, the total share number is constituted by 44,806 shares held by Peter Slabbert, 141,821 shares held by Desiree Slabbert and 15,800 shares held by Simon Slabbert. In the case of Andrew Lewis, the total share number is constituted by 25,092 shares held by Andrew Lewis and 95,800 shares held by Karen Lewis. In the case of Miles Ingrey-Counter, the total share number is constituted by 10,324 shares held by Miles Ingrey-Counter and 29,716 shares held by Emma Ingrey-Counter. In the case of Paul McDonald, the total share number is constituted by 18,437 shares held by Paul McDonald and 20,437 shares held by Deborah McDonald. John Kime's shareholding is in his own name.

Other employees accounted for total awards of 166,773 shares. Other UK participants sold their jointly owned interests in 76,321 shares and acquired nil cost options over 28,774 whole shares, of which 6,237 were sold for personal reasons. Other US participants acquired 90,452 whole shares of which 67,379 were sold to pay tax and for personal reasons.

 

Contact Information:

Peter Slabbert, Chief Executive

01225 896870

Andrew Lewis, Group Finance Director

Miles Ingrey-Counter, Company Secretary

01225 896830

01225 896850

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUKRVROAAAUAA
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.